SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/A43D4813769D4373CE6F4AAC732F04D9D955F16792145F023356F37222E6D83A227D3ECD73540143092BB3CE3805C3C6>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/A43D4813769D4373CE6F4AAC732F04D9D955F16792145F023356F37222E6D83A227D3ECD73540143092BB3CE3805C3C6
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/A43D4813769D4373CE6F4AAC732F04D9D955F16792145F023356F37222E6D83A227D3ECD73540143092BB3CE3805C3C6
http://www.w3.org/2000/01/rdf-schema#comment
"The class II beta-tubulin isotype seems to be a promising predictive marker of docetaxel activity in the treatment of breast neoplasms."
xsd:string
http://purl.uniprot.org/uniprot/#_3CEFF10A4973D8832C733115D5E2CC31F1E4106B6303F8D11401EC42C8ABC6914822FB427E6630A7F4261FA0B3300481
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/A43D4813769D4373CE6F4AAC732F04D9D955F16792145F023356F37222E6D83A227D3ECD73540143092BB3CE3805C3C6
http://purl.uniprot.org/uniprot/Q9BVA1
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/A43D4813769D4373CE6F4AAC732F04D9D955F16792145F023356F37222E6D83A227D3ECD73540143092BB3CE3805C3C6
http://purl.uniprot.org/uniprot/#_Q9BVA1-mappedCitation-12533264
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/A43D4813769D4373CE6F4AAC732F04D9D955F16792145F023356F37222E6D83A227D3ECD73540143092BB3CE3805C3C6